Biocon has announced a bold step in the biopharmaceutical landscape by merging its biosimilars division, Biocon Biologics, into the parent organization for $5.5 billion. This ambitious strategy is ...

Biocon to acquire stakes via share swaps with Serum Institute, Tata Capital, Activ Pine Shreehas Tambe to lead combined entity as CEO, managing director Biocon reviewed IPO, merger options before ...

Biocon Biologics to sell Denosumab biosimilars in Europe by Dec 2025. Settlement with Amgen expands Biocon's reach in oncology and bone health. Biocon's US and Europe settlements boost global ...

Biocon Ltd is considering merging its biosimilars arm, Biocon Biologics Ltd, with the parent entity, according to people cited by The Economic Times. The deal, which could value the subsidiary at ...

Kiran Mazumdar-Shaw, Biocon founder and a key voice of India Inc., met Karnataka Chief Minister Siddaramaiah and Deputy Chief Minister DK Shivakumar at their homes in Bengaluru this morning. The ...

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...

Rifaximin tablets are indicated for reducing the risk of overt hepatic encephalopathy (HE) recurrence and to treat irritable bowel syndrome with diarrhoea (IBS-D) in adults. Biocon on Tuesday said its ...

In late 1994, controversy was brewing over royalties being imposed on GIFs due to the Lempel–Ziv–Welch (LZW) data compression technique used to underpin this image format. Unisys, which had patented ...

Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon has received the US Food and Drug Administration (FDA) approval for Bosaya (denosumab-kyqq) 60 mg/mL injection ...

The Ontario Drug Benefit (ODB) Formulary is the official listing that determines which prescription medicines are covered under the public insurance system in Ontario, Canada's largest province. This ...

New Delhi: Indian biopharmaceutical company Biocon on Thursday announced the opening of its first manufacturing plant in the US. The US-FDA-approved facility, operated by Biocon’s wholly-owned ...